10-18140752-AT-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_201596.3(CACNB2):c.17delT(p.Met6SerfsTer21) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,442,932 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_201596.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000476 AC: 1AN: 210142Hom.: 0 AF XY: 0.00000872 AC XY: 1AN XY: 114676
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1442932Hom.: 0 Cov.: 32 AF XY: 0.00000279 AC XY: 2AN XY: 715838
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.17delT variant has not been published as a mutation or reported as a benign polymorphism to our knowledge. This variant occurs in an alternate transcript of the CACNB2 gene. No definitive loss of function mutations in the CACNB2 gene have been reported in association with familial arrhythmia suggesting that haploinsufficiency may not be a disease mechanism for CACNB2-associated arrhythmia. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. -
CACNB2-related disorder Uncertain:1
The CACNB2 c.17delT variant is predicted to result in a frameshift and premature protein termination (p.Met6Serfs*21). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-18429681-AT-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at